Pluvicto 1 000 MBq/mL solution for injection/infusion
EORTC-2361-GUCG
Phase 2 small_molecule active
Quick answer
Pluvicto 1 000 MBq/mL solution for injection/infusion for Clear Cell Renal Cell Carcinoma (ccRCC) is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Clear Cell Renal Cell Carcinoma (ccRCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active